HEOMX
Price
$17.32
Change
-$0.13 (-0.74%)
Updated
Sep 20 closing price
RWIBX
Price
$66.87
Change
-$0.15 (-0.22%)
Updated
Sep 20 closing price
Ad is loading...

HEOMX vs RWIBX

Header iconHEOMX vs RWIBX Comparison
Open Charts HEOMX vs RWIBXBanner chart's image
Hartford Climate Opportunities A
Price$17.32
Change-$0.13 (-0.74%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R2
Price$66.87
Change-$0.15 (-0.22%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
HEOMX vs RWIBX Comparison Chart
Loading...
VS
HEOMX vs. RWIBX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HEOMX is a StrongBuy and RWIBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 128B vs. HEOMX (139M). RWIBX pays higher dividends than HEOMX: RWIBX (1.05) vs HEOMX (0.34). HEOMX was incepted earlier than RWIBX: HEOMX (9 years) vs RWIBX (22 years). HEOMX is a more actively managed with annual turnover of: 75.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than HEOMX: RWIBX (250) vs HEOMX (2000). RWIBX annual gain was more profitable for investors over the last year : 23.75 vs. HEOMX (21.05). HEOMX return over 5 years is better than : 66.90 vs. RWIBX (42.68).
HEOMXRWIBXHEOMX / RWIBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years22 years-
Gain YTD12.24913.56290%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets139M128B0%
Annual Yield % from dividends0.341.0532%
Returns for 1 year21.0523.7589%
Returns for 3 years-0.407.37-5%
Returns for 5 years66.9042.68157%
Returns for 10 yearsN/A49.04-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNFT4.940.75
+17.90%
Genfit SA
NNI112.94-2.01
-1.75%
Nelnet
ILMN131.14-3.25
-2.42%
Illumina
SPRB0.44-0.01
-2.59%
Spruce Biosciences
APLT7.70-0.30
-3.75%
Applied Therapeutics